As of 2025-10-25, the Relative Valuation of Homology Medicines Inc (FIXX) is (152.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -721.9%.
The range of the Relative Valuation is (173.03) - (106.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.8x - 1.3x | 1.0x |
| Forward P/E multiples | 2.0x - 3.1x | 2.6x |
| Fair Price | (173.03) - (106.87) | (152.67) |
| Upside | -804.8% - -535.3% | -721.9% |
| Date | P/E |